EPL (500135) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
20 Nov, 2025Executive summary
Q4 FY25 saw revenue growth of 7.4%, EBITDA up 17.7%, and adjusted PAT up 42.4% year-over-year, with 11 consecutive quarters of EBITDA margin above 20%.
Full-year FY25 revenue grew 7.6% to Rs. 42,133 million, EBITDA up 17.5%, and adjusted PAT up 44.6%; EPS improved to INR 11.38.
'Personal Care & Beyond' contributed 48% of tube revenue, growing at 10.3% YoY, with beauty and cosmetics segment delivering over 20% growth in Q4.
Sustainability initiatives advanced, with 33% of the portfolio now recyclable, EcoVadis Gold rating, and multiple ESG awards.
Audited results approved with an unmodified opinion; final dividend of Rs. 2.50 per share recommended.
Financial highlights
Q4FY25 revenue: INR 11,054 million (+7.4% YoY); EBITDA: INR 2,246 million (+17.7% YoY, margin 20.3%); adjusted PAT: INR 1,179 million (+42.4% YoY); adjusted EPS: INR 3.69.
FY25 consolidated revenue: Rs. 42,133 million (+7.6% YoY); net profit after tax: Rs. 3,638 million (+73.2% YoY); consolidated EPS: Rs. 11.27.
Net debt reduced to INR 4,568 million (Net Debt/EBITDA: 0.54x); ROCE improved to 18%.
Final dividend proposed at Rs. 2.50 per share for FY25.
Capex for FY25 was INR 3,631 million.
Outlook and guidance
Targeting sustained double-digit revenue growth and continued margin expansion, led by 'Personal Care & Beyond' and sustainability.
Capacity expansion in Brazil and new greenfield plant in Thailand to support growth.
CapEx for FY26 planned at INR 380-390 crore, supporting growth and greenfield projects.
Minimal impact expected from US tariffs due to local manufacturing and contractual pass-throughs.
Board recommended a final dividend, reflecting confidence in future cash flows and profitability.
Latest events from EPL
- Double-digit revenue and EBITDA growth, led by beauty and cosmetics, with improved ROCE.500135
Q3 25/2613 Feb 2026 - Double-digit growth, margin expansion, and sustainability-led gains across all regions.500135
Q1 24/252 Feb 2026 - Q2 FY25 delivered strong growth, margin expansion, and a declared interim dividend.500135
Q2 24/2515 Jan 2026 - EBITDA margin hit 20.3% with robust profit growth and expansion in key segments.500135
Q3 24/2523 Dec 2025 - Double-digit growth, margin expansion, and strong beauty/cosmetics momentum drive outlook.500135
Q1 25/2623 Nov 2025 - Double-digit growth, margin expansion, and sustainability leadership achieved.500135
Q2 25/2618 Nov 2025